Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Muylle

Showing results (11-20 of 69) with videos related to

Pageof 7
Sort By:
Infection|July 1, 1989
Hepatitis B core antibody-negative HBsAg carriersR Vranckx, L Muylle, A Meheus
Revue D'Epidemiologie Et De Sante Publique|January 1, 1984
In Belgium, viral hepatitis A is predominantly childhood diseaseR Vranckx, L Muylle, J Cole
Acta Clinica Belgica|January 1, 1984
Acquired B-antigen in a patient with a colo-vesical fistulaL Muylle, P Gentens, W Vaneerdeweg
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1986
Binding of serum ferritin to concanavalin A in patients with malignancyL Muylle, P Blockx, D Becquart
Transfusion Science|August 5, 1997
Possible implication of sterile connecting device in contamination of pooled platelet concentratesG Mertens, L Muylle, H Goossens
AIDS Research and Human Retroviruses|July 1, 1990
A seroepidemiological survey of HTLV-I/HTLV-II in selected Belgian populationsR Vranckx, A Coenjaert, L Muylle
Transfusion Science|September 5, 1993
Separation of buffy coat using the top and bottom drainage system: reduction of red blood cell lossL Muylle, D Eerens, B Van Breedam
The New England Journal of Medicine|February 27, 1986
No HTLV-III antibodies after HBV vaccinationL Muylle, P Vranckx, M E Peetermans
Transfusion|October 1, 1996
Febrile reactions to platelet transfusion: the effect of increased interleukin 6 levels in concentrates prepared by the platelet-rich plasma methodL Muylle, E Wouters, M E Peetermans
Vox Sanguinis|March 16, 2000
Malaria antibody ELISA insufficiently sensitive for blood donor screeningG Mertens, T Vervoort, S Heylen, et al.
Pageof 7

Showing results (11-20 of 69) with videos related to

Sort By:
Pageof 7
Infection|July 1, 1989
Hepatitis B core antibody-negative HBsAg carriersR Vranckx, L Muylle, A Meheus
Revue D'Epidemiologie Et De Sante Publique|January 1, 1984
In Belgium, viral hepatitis A is predominantly childhood diseaseR Vranckx, L Muylle, J Cole
Acta Clinica Belgica|January 1, 1984
Acquired B-antigen in a patient with a colo-vesical fistulaL Muylle, P Gentens, W Vaneerdeweg
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1986
Binding of serum ferritin to concanavalin A in patients with malignancyL Muylle, P Blockx, D Becquart
Transfusion Science|August 5, 1997
Possible implication of sterile connecting device in contamination of pooled platelet concentratesG Mertens, L Muylle, H Goossens
AIDS Research and Human Retroviruses|July 1, 1990
A seroepidemiological survey of HTLV-I/HTLV-II in selected Belgian populationsR Vranckx, A Coenjaert, L Muylle
Transfusion Science|September 5, 1993
Separation of buffy coat using the top and bottom drainage system: reduction of red blood cell lossL Muylle, D Eerens, B Van Breedam
The New England Journal of Medicine|February 27, 1986
No HTLV-III antibodies after HBV vaccinationL Muylle, P Vranckx, M E Peetermans
Transfusion|October 1, 1996
Febrile reactions to platelet transfusion: the effect of increased interleukin 6 levels in concentrates prepared by the platelet-rich plasma methodL Muylle, E Wouters, M E Peetermans
Vox Sanguinis|March 16, 2000
Malaria antibody ELISA insufficiently sensitive for blood donor screeningG Mertens, T Vervoort, S Heylen, et al.
Pageof 7